Nested Therapeutics to Present Preclinical Data for Novel, Potential Best-in-Class Inhibitor of the RAS/MAPK Pathway at 2023 AACR-NCI-EORTC Conference

/PRNewswire/ -- Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today...

Related Keywords

Boston ,Massachusetts ,United States ,Hynes Convention Center ,Cambridge ,Cambridgeshire ,United Kingdom , ,International Conference ,Therapeutics Inc ,Linkedin ,Hynes Convention ,Poster Session ,Nested Therapeutics ,Nc ,